The potential economic value of a Trypanosoma cruzi (Chagas disease) vaccine in Latin America.
Chagas disease, caused by the parasite Trypanosoma cruzi (T. cruzi), is the leading etiology of non-ischemic heart disease worldwide, with Latin America bearing the majority of the burden. This substantial burden and the limitations of current interventions have motivated efforts to develop a vaccin...
Main Authors: | Bruce Y Lee, Kristina M Bacon, Diana L Connor, Alyssa M Willig, Rachel R Bailey |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2010-12-01
|
Series: | PLoS Neglected Tropical Diseases |
Online Access: | http://europepmc.org/articles/PMC3001903?pdf=render |
Similar Items
-
Prevention of transfusional Trypanosoma cruzi infection in Latin America
by: Gabriel A Schmunis
Published: (1999-09-01) -
Modelling geospatial distributions of the triatomine vectors of Trypanosoma cruzi in Latin America.
by: Andreas Bender, et al.
Published: (2020-08-01) -
The economic value of identifying and treating Chagas disease patients earlier and the impact on Trypanosoma cruzi transmission.
by: Sarah M Bartsch, et al.
Published: (2018-11-01) -
Meiotic sex in Chagas disease parasite Trypanosoma cruzi
by: Philipp Schwabl, et al.
Published: (2019-09-01) -
Trypanosoma cruzi loop-mediated isothermal amplification (Trypanosoma cruzi Loopamp) kit for detection of congenital, acute and Chagas disease reactivation.
by: Susana A Besuschio, et al.
Published: (2020-08-01)